The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 752K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

10 articles for RM Vitale


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Avarol derivatives as competitive AChE inhibitors, non hepatotoxic and neuroprotective agents for Alzheimer's disease.EBI
Istituto Di Chimica Biomolecolare (Icb)
Structure-activity relationships and molecular modelling of new 5-arylidene-4-thiazolidinone derivatives as aldose reductase inhibitors and potential anti-inflammatory agents.EBI
University of Messina
Molecular modeling study for the binding of zonisamide and topiramate to the human mitochondrial carbonic anhydrase isoform VA.EBI
Istituto Di Biostrutture E Bioimmagini-Cnr
Phytochemical Characterization and TRPA1/TRPM8 Modulation Profile of the Cannabigerol-Rich EBI
University of Naples Federico Ii
Discovery of a Remarkable Methyl Shift Effect in the Vanilloid Activity of Triterpene Amides.EBI
National Research Council (Icb-Cnr)
Cannabitwinol, a Dimeric Phytocannabinoid from Hemp, EBI
University of Naples Federico Ii
Tetrahydroisoquinoline-Derived Urea and 2,5-Diketopiperazine Derivatives as Selective Antagonists of the Transient Receptor Potential Melastatin 8 (TRPM8) Channel Receptor and Antiprostate Cancer Agents.EBI
National Research Council
Elongation of the Hydrophobic Chain as a Molecular Switch: Discovery of Capsaicin Derivatives and Endogenous Lipids as Potent Transient Receptor Potential Vanilloid Channel 2 Antagonists.EBI
National Research Council (Cnr)
Heteroaryl-pyrimidinone compounds as PDE2 inhibitorsBDB
Merck Sharp & Dohme
Acylguanidines for treating osteoarthritisBDB
Merck Patent